Myron Czuczman - 11 Oct 2021 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Medical Officer
Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
11 Oct 2021
Net transactions value
$0
Form type
4
Filing time
13 Oct 2021, 17:25:13 UTC
Next filing
06 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +300,000 $0.000000 300,000 11 Oct 2021 Common Stock 300,000 $2.04 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 500,000 11 Oct 2021 Common Stock 500,000 $1.19 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F2 One-third of the shares of the Company's common stock underlying the grant vest on the one-year anniversary of the Vesting Commencement Date, July 14, 2020, with the remainder vesting in 24 equal monthly installments thereafter, provided that the Optionee provides Continuous Service to the Company on each such vesting date.